Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Marquez-Martin, C. Calero Acuña, J. L. Lopez-Campos, R. Sanchez Silva, P. Cejudo Ramos, L. Gomez Izquierdo, F. Ortega Ruiz, J. J. Toledo Aral, E. Rodriguez Becerra, E. Barrot Cortes, M. Echevarria (Seville, Spain). Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients. Eur Respir J 2009; 34: Suppl. 53, 4768

Member's Comments

No comment yet.

Related content which might interest you: Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001 Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 Mortality in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 210s Year: 2001 Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 226s Year: 2007 Emphysema contribution to the progression of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 654s Year: 2006 Large airways remodeling in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2008 - Pathophysiology of respiratory diseases Year: 2008 Systemic and pulmonary inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Disease of the airways in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 41S-49S Year: 2001 IL-8 in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 364s Year: 2001 Inferon administration to patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Functional and inflammatory bowel diseases in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 The dynamic lung volume analysis in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 212s Year: 2005 The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007 Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Angiogenic status in patients with chronic obstructive pulmonary disease. Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009